Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Licht

Showing results (11-20 of 172) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2014
Molecular pathways: deregulation of histone h3 lysine 27 methylation in cancer-different paths, same destinationTeresa Ezponda, Jonathan D Licht
Blood|February 26, 2011
MEK and MAF in myeloma therapyRelja Popovic, Jonathan D Licht
Current Opinion in Hematology|June 4, 2002
Histone deacetylases as therapeutic targets in hematologic malignanciesAri Melnick, Jonathan D Licht
Cancer Discovery|May 17, 2012
Emerging epigenetic targets and therapies in cancer medicineRelja Popovic, Jonathan D Licht
Nature Genetics|March 30, 2011
DNMT3A mutations in acute myeloid leukemiaMrinal Y Shah, Jonathan D Licht
Oncotarget|February 9, 2017
FQI1: a transcription-methylation switch for cancerOlga A Guryanova, Jonathan D Licht
Nature Genetics|January 28, 2010
Deregulation of H3K27 methylation in cancerEva Martinez-Garcia, Jonathan D Licht
Hematology. American Society of Hematology. Education Program|November 24, 2005
The molecular pathology of acute myeloid leukemiaJonathan D Licht, David W Sternberg
Clinical Epigenetics|May 18, 2021
Leveraging epigenetics to enhance the efficacy of immunotherapyJonathan D Licht, Richard L Bennett
Cancer Cell|December 16, 2010
Partners in crime: Genes within an amplicon collude to globally deregulate chromatin in lymphomaDong-Joon Min, Jonathan D Licht
Pageof 18

Showing results (11-20 of 172) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2014
Molecular pathways: deregulation of histone h3 lysine 27 methylation in cancer-different paths, same destinationTeresa Ezponda, Jonathan D Licht
Blood|February 26, 2011
MEK and MAF in myeloma therapyRelja Popovic, Jonathan D Licht
Current Opinion in Hematology|June 4, 2002
Histone deacetylases as therapeutic targets in hematologic malignanciesAri Melnick, Jonathan D Licht
Cancer Discovery|May 17, 2012
Emerging epigenetic targets and therapies in cancer medicineRelja Popovic, Jonathan D Licht
Nature Genetics|March 30, 2011
DNMT3A mutations in acute myeloid leukemiaMrinal Y Shah, Jonathan D Licht
Oncotarget|February 9, 2017
FQI1: a transcription-methylation switch for cancerOlga A Guryanova, Jonathan D Licht
Nature Genetics|January 28, 2010
Deregulation of H3K27 methylation in cancerEva Martinez-Garcia, Jonathan D Licht
Hematology. American Society of Hematology. Education Program|November 24, 2005
The molecular pathology of acute myeloid leukemiaJonathan D Licht, David W Sternberg
Clinical Epigenetics|May 18, 2021
Leveraging epigenetics to enhance the efficacy of immunotherapyJonathan D Licht, Richard L Bennett
Cancer Cell|December 16, 2010
Partners in crime: Genes within an amplicon collude to globally deregulate chromatin in lymphomaDong-Joon Min, Jonathan D Licht
Pageof 18